Tokushima University / Educator and Researcher Directory --- Kamimura, Seiichiro

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Ryo Kanamura, Junya Fukuda, Eiji Kondou, Takahiro Azuma, Gou Satou and Noriaki Takeda : Long-term changes in serum squamous cell carcinoma antigen levels after surgery in patients with sinonasal inverted papilloma, Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho, Vol.127, No.3, 187-188, 2024. (Tokushima University Institutional Repository) ● Metadata: 119287 (Link to Publication Site) ● Publication site (DOI): 10.3950/jibiinkotokeibu.127.3_187 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390862623771870720 ● Search Scopus @ Elsevier (DOI): 10.3950/jibiinkotokeibu.127.3_187 (Tokushima University Institutional Repository: 119287, DOI: 10.3950/jibiinkotokeibu.127.3_187, CiNii: 1390862623771870720)
2.	Seiichiro Kamimura, Koji Abe, Katsuya Fujino, Kazunori Matsuda and Yoshiaki Kitamura : A Case of Solitary Plasmacytoma of the Tongue, Practica Oto-Rhino-Laryngologica, Vol.116, No.12, 1211-1216, 2023. (Link to Publication Site) ● Publication site (DOI): 10.5631/jibirin.116.1211 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390016880929589632 ● Search Scopus @ Elsevier (DOI): 10.5631/jibirin.116.1211 (DOI: 10.5631/jibirin.116.1211, CiNii: 1390016880929589632)
3.	Miyu Kubo, Sonoko Yasui-Yamada, Haruka Hayashi, Midori Kitao, Kyoko Wada, Ayaka Yamanaka, Nao Ohmae, Momoyo Matsuoka, Seiichiro Kamimura, Aki Shimada, Yoshiaki Kitamura and Yasuhiro Hamada : Development and validation of equations for predicting appendicular skeletal muscle mass in male patients with head and neck cancer and normal hydration status, Nutrition, Vol.116, 112184, 2023. (Summary) Muscle mass is typically assessed by abdominal computed tomography, magnetic resonance imaging, and dual-energy x-ray absorptiometry. However, these tests are not routinely performed in patients with head and neck cancer (HNC), making sarcopenia assessment difficult. The aim of this study was to develop and validate equations for predicting appendicular skeletal muscle mass (ASM) from data obtained in daily medical practice, with bioelectrical impedance analysis (BIA)-measured appendicular skeletal muscle mass (BIA-ASM) as a reference. This cross-sectional study included 103 men with HNC who were randomly placed into development and validation groups. The prediction equations for BIA-ASM were developed by multiple regression analysis and validated by Bland-Altman analyses. The estimated skeletal muscle mass index (eSMI) was also statistically evaluated to discriminate the cutoff value for BIA-measured SMI according to the Asian Working Groups for Sarcopenia. Two practical equations, which included 24-h urinary creatinine excretion volume (24hUCrV), handgrip strength (HGS), body weight (BW), and body height (BHt), were developed: ASM (kg) = -39.46 + (3.557 × 24hUCrV [g]) + (0.08872 × HGS [kg]) + (0.1263 × BW [kg]) + (0.2661 × BHt [cm]) if available for 24hUCrV (adjusted R = 0.8905), and ASM (kg) = -42.60 + (0.1643 × HGS [kg]) + (0.1589 × BW [kg]) + (0.2807 × BHt [cm]) if not (adjusted R = 0.8589). ASM estimated by these two equations showed a significantly strong correlation with BIA-ASM (R > 0.900). Bland-Altman analyses showed a good agreement, and eSMI accuracy was high (>80%) in both equations. These two equations are a valid option for estimating ASM and diagnosing sarcopenia in patients with HNC in all facilities without special equipment. (Keyword) Humans / Male / Sarcopenia / Cross-Sectional Studies / Hand Strength / Muscle, Skeletal / Body Composition / Body Weight / Head and Neck Neoplasms / Absorptiometry, Photon / Electric Impedance (Tokushima University Institutional Repository) ● Metadata: 119183 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2023.112184 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37678015 ● Search Scopus @ Elsevier (PMID): 37678015 ● Search Scopus @ Elsevier (DOI): 10.1016/j.nut.2023.112184 (Tokushima University Institutional Repository: 119183, DOI: 10.1016/j.nut.2023.112184, PubMed: 37678015)
4.	Seiichiro Kamimura, Keisuke Ishitani, Takahiro Azuma and Yoshiaki Kitamura : A Case of Eosinophilic Granulomatosis with Polyangiitis That Developed After the Initial Administration of Dupilumab, Practica Oto-Rhino-Laryngologica, Vol.116, No.11, 1097-1102, 2023. (Link to Publication Site) ● Publication site (DOI): 10.5631/jibirin.116.1097 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390579454814998144 ● Search Scopus @ Elsevier (DOI): 10.5631/jibirin.116.1097 (DOI: 10.5631/jibirin.116.1097, CiNii: 1390579454814998144)
5.	Seiichiro Kamimura, Yuki Ishitani, ISHITANI Keisuke, TOMURA Miki, Aki Endo, Ryo Kanamura, Hitoshi Shono, Eiji Kondou, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : A case of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma of the posterior end of the nasal septum, JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY, Vol.33, No.2, 257-261, 2023. (Keyword) Thyroid-like low grade nasopharyngeal papillary adenocarcinoma，thyroid transcription factor-1 / thyroglobulin / 鼻中隔後端 / 内視鏡手術 / thyroid-like low-grade nasopharyngeal papillary adenocarcinoma, thyroid transcription factor-1 / posterior edge of nasal septum / endoscopic surgery (Link to Publication Site) ● Publication site (DOI): 10.5106/jjshns.33.257 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390860996982918912 ● Search Scopus @ Elsevier (DOI): 10.5106/jjshns.33.257 (DOI: 10.5106/jjshns.33.257, CiNii: 1390860996982918912)
6.	Nao Omae, Sonoko Yasui-Yamada, Taiki Furumoto, Kyoko Wada, Haruka Hayashi, Midori Kitao, YAMANAKA Ayaka, Miyu Kubo, Momoyo Matsuoka, Seiichiro Kamimura, Aki Shimada, Nori Sato, Yoshiaki Kitamura, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : Muscle mass, quality, and strength; physical function and activity; and metabolic status in cachectic patients with head and neck cancer., Clinical Nutrition ESPEN, Vol.53, 113-119, 2023. (Summary) Cancer cachexia is commonly associated with poor prognosis in patients with head and neck cancer (HNC). However, its pathophysiology and treatment are not well established. The current study aimed to assess the muscle mass/quality/strength, physical function and activity, resting energy expenditure (REE), and respiratory quotient (RQ) in cachectic patients with HNC. This prospective cross-sectional study analyzed 64 patients with HNC. Body composition was measured via direct segmental multifrequency bioelectrical impedance analysis, and muscle quality was assessed using echo intensity on ultrasonography images. Muscle strength was investigated utilizing handgrip strength and isometric knee extension force (IKEF). Physical function was evaluated using the 10-m walking speed test and the five times sit-to-stand (5-STS) test. Physical activity was examined using a wearable triaxial accelerometer. REE and RQ were measured via indirect calorimetry. These parameters were compared between the cachectic and noncachectic groups. In total, 23 (36%) patients were diagnosed with cachexia. The cachectic group had a significantly lower muscle mass than the noncachectic group. Nevertheless, there was no significant difference in terms of fat between the two groups. The cachectic group had a higher quadriceps echo intensity and a lower handgrip strength and IKEF than the noncachectic group. Moreover, they had a significantly slower normal and maximum walking speed and 5-STS speed. The number of steps, total activity time, and time of activity (<3 Mets) did not significantly differ between the two groups. The cachectic group had a shorter time of activity (≥3 Mets) than the noncachectic group. Furthermore, the cachectic group had a significantly higher REE/body weight and REE/fat free mass and a significantly lower RQ than the noncachectic group. The cachectic group had a lower muscle mass/quality/strength and physical function and activity and a higher REE than the noncachectic group. Thus, REE and physical activity should be evaluated to determine energy requirements. The RQ was lower in the cachectic group than that in the noncachectic group, indicating changes in energy substrate. Further studies must be conducted to examine effective nutritional and exercise interventions for patients with cancer cachexia. (Keyword) Humans / Cachexia / Hand Strength / Cross-Sectional Studies / Prospective Studies / Head and Neck Neoplasms / Quadriceps Muscle (Tokushima University Institutional Repository) ● Metadata: 118202 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnesp.2022.12.006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36657901 ● Search Scopus @ Elsevier (PMID): 36657901 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clnesp.2022.12.006 (Tokushima University Institutional Repository: 118202, DOI: 10.1016/j.clnesp.2022.12.006, PubMed: 36657901)
7.	Gou Satou, Seiichiro Kamimura, Keisuke Ishitani, Aki Endo, Junya Fukuda, Ryo Kanamura, Hitoshi Shono, Eiji Kondou, Takahiro Azuma and Yoshiaki Kitamura : Effect of Surgical Training Using a Virtual Reality Sinus Simulator in Medical Education, Japanese Journal of Rhinology, Vol.62, No.4, 598-604, 2023. (Link to Publication Site) ● Publication site (DOI): 10.7248/jjrhi.62.598 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390017046607588352 ● Search Scopus @ Elsevier (DOI): 10.7248/jjrhi.62.598 (DOI: 10.7248/jjrhi.62.598, CiNii: 1390017046607588352)
8.	Ayaka Yamanaka, Sonoko Yasui-Yamada, Taiki Furumoto, Miyu Kubo, Haruka Hayashi, Midori Kitao, Kyoko Wada, Nao Ohmae, Seiichiro Kamimura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : Association of phase angle with muscle function and prognosis in patients with head and neck cancer undergoing chemoradiotherapy, Nutrition, 111798, 2022. (Summary) Objective: We aimed to investigate the correlation of phase angle (PhA) with other parameters (e.g., muscle mass/quality/strength and physical function), assess the prognostic relevance of pre-chemoradiotherapy (CRT) PhA, and suggest a reference value of PhA in Asian patients with head and neck cancer (HNC). Research Methods & Procedures: Ninety-six patients with HNC who underwent CRT were divided into two groups, maintained-PhA group and low-PhA group, according to the PhA 25th percentile values by sex. Pretreatment PhA was measured using direct segmental multi-frequency bioelectrical impedance analysis, and muscle quality was assessed using echo intensity in ultrasound images. Correlation of PhA with other parameters was investigated, and between-group differences with respect to adverse events, treatment interruption, and 3-year survival were assessed. Results: PhA showed a positive correlation with isometric knee extension force (R = 0.710), handgrip strength (R = 0.649), skeletal muscle mass index (R = 0.620), and maximum gait speed (R = 0.543) (P < 0.001). PhA showed a negative correlation with echo intensity (R = -0.439) and five times sit-to-stand test (R = -0.505) (P < 0.01). The low-PhA group had a higher incidence of severe anemia (52% in low-PhA vs. 17% in maintained-PhA), aspiration (17% vs. 1%), radiotherapy interruption (17% vs. 3%), and poor 3-year survival (47% vs. 81%) than the maintained-PhA group (P < 0.05). Conclusion: PhA was correlated with muscle mass/quality/strength, and physical function. Low PhA was associated with severe adverse events, treatment interruption, and shorter survival. These findings suggested that 4.6° for men and 4.0° for women may be useful as prognostic reference values in Asian patients with HNC. (Keyword) Phase angle / Muscle strength / Muscle quality / Physical function / Prognosis / Head and neck cancer (Tokushima University Institutional Repository) ● Metadata: 117379 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2022.111798 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1360298757183486592 ● Search Scopus @ Elsevier (DOI): 10.1016/j.nut.2022.111798 (Tokushima University Institutional Repository: 117379, DOI: 10.1016/j.nut.2022.111798, CiNii: 1360298757183486592)
9.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Fukui, Hiroyuki Mizuguchi and Noriaki Takeda : Development of a Phototherapy Device for Allergic Rhinitis Using LEDs Emitting Narrowband UVB, Practica Oto-Rhino-Laryngologica. Suppl., Vol.158, No.0, 20-28, 2022. (Keyword) allergic rhinitis / apoptosis / histamine H1 receptor / narrow-band ultraviolet B / phototherapy (Link to Publication Site) ● Publication site (DOI): 10.5631/jibirinsuppl.158.20 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390292085430058368 ● Search Scopus @ Elsevier (DOI): 10.5631/jibirinsuppl.158.20 (DOI: 10.5631/jibirinsuppl.158.20, CiNii: 1390292085430058368)
10.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura, Keisuke Ishitani and Noriaki Takeda : Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens., Laryngoscope Investigative Otolaryngology, Vol.7, No.1, 36-42, 2022. (Summary) 3b, a case-controlled study. (Tokushima University Institutional Repository) ● Metadata: 118083 (Link to Publication Site) ● Publication site (DOI): 10.1002/lio2.740 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35155781 ● Search Scopus @ Elsevier (PMID): 35155781 ● Search Scopus @ Elsevier (DOI): 10.1002/lio2.740 (Tokushima University Institutional Repository: 118083, DOI: 10.1002/lio2.740, PubMed: 35155781)
11.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Ryo Kanamura, Junya Fukuda, Eiji Kondou, Takahiro Azuma, Gou Satou and Noriaki Takeda : Long-term changes in serum squamous cell carcinoma antigen levels after surgery in patients with sinonasal inverted papilloma., Auris, Nasus, Larynx, Vol.49, No.4, 697-702, 2022. (Summary) These findings suggest that SCCA can be a tumor marker of IP. It is also suggested that postoperative elevation of SCCA levels is a clinical marker for monitoring the recurrence of IP during the follow-up period. A SCCA cut-off value of 1.85 ng/ml postoperatively may predict the subsequent recurrence of IP with high sensitivity and specificity. (Keyword) Antigens, Neoplasm / Humans / Nose Neoplasms / Papilloma, Inverted / Paranasal Sinus Neoplasms / Serpins (Link to Publication Site) ● Publication site (DOI): 10.1016/j.anl.2021.12.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34996617 ● Search Scopus @ Elsevier (PMID): 34996617 ● Search Scopus @ Elsevier (DOI): 10.1016/j.anl.2021.12.004 (DOI: 10.1016/j.anl.2021.12.004, PubMed: 34996617)
12.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis., The Journal of Medical Investigation : JMI, Vol.69, No.1.2, 97-100, 2022. (Summary) It is suggested that SLIT with JCP tablets improved both nasal symptoms and sleep disturbances at peak pollen period in patients with Japanese cedar pollinosis. SLIT with JCP tablets for one year was more effective than SLIT with JCP drops for two years and prophylactic treatment with antihistamines. J. Med. Invest. 69 : 97-100, February, 2022. (Keyword) Allergens / Cryptomeria / Humans / Pollen / Rhinitis, Allergic, Seasonal / Sleep / Sublingual Immunotherapy / Tablets (Tokushima University Institutional Repository) ● Metadata: 117018 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.69.97 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35466153 ● CiNii @ National Institute of Informatics (CRID): 1390573407640009984 ● Search Scopus @ Elsevier (PMID): 35466153 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.69.97 (Tokushima University Institutional Repository: 117018, DOI: 10.2152/jmi.69.97, PubMed: 35466153, CiNii: 1390573407640009984)
13.	Seiichiro Kamimura, Katsuya Fujino, Keisuke Naito, Yoshiaki Kitamura and Noriaki Takeda : A Case of Hereditary Angioedema who Underwent Endoscopic Sinus Surgery Under General Anesthesia, Practica Oto-Rhino-Laryngologica, Vol.114, No.5, 391-396, 2021. (Summary) <p>Hereditary angioedema (HAE) is an inherited disease characterized by angioedema, that is caused by a genetic abnormality of C1-inhibitor (C1-INH). Decrease or functional abnormality of the C1-INH protein leads to excessive production of bradykinin, which causes increased vascular permeability. Patients with HAE present with edema of the face, arms and legs, as also of the larynx and gastrointestinal tract. Notably, airway stenosis caused by laryngeal edema can be fatal. Upper airway surgery under general anesthesia in patients with HAE carries the risk of airway stenosis caused by surgical site edema and by laryngeal edema due to tracheal intubation. In one guideline for the management of HAE, administration of C1-INH (Berinert<sup>®</sup>P) prior to surgery is recommended as prophylaxis against the development of angioedema.</p><p>A 68-year-old female patient with HAE (type 1) was referred to our department with the chief complaint of pain in the right maxilla. She had undergone Caldwell-Luc surgery for sinusitis as a 13-year-old. CT showed two cysts in the right maxilla, and she was diagnosed as having maxillary cysts and scheduled for surgery. As she suffered from frequent attacks of HAE, we administered C1-INH to the patient prior to surgery, according to a guideline for the management of HAE, and the patient underwent endoscopic sinus surgery (ESS) under general anesthesia without HAE attacks during the perioperative period.</p><p>ESS under general anesthesia in a patient with HAE carries the risk of angioedema developing at the surgical site and laryngeal edema developing as a result of tracheal intubation. We could safely perform ESS without angioedema developing in the perioperative period, by prophylactic administration of C1-INH according to a guideline for the management of HAE.</p> (Keyword) hereditary angioedema / endoscopic sinus surgery / C1-inhibitor / maxillary cyst (Link to Publication Site) ● Publication site (DOI): 10.5631/jibirin.114.391 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390569382247330944 ● Search Scopus @ Elsevier (DOI): 10.5631/jibirin.114.391 (DOI: 10.5631/jibirin.114.391, CiNii: 1390569382247330944)
14.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura, Keisuke Naito and Noriaki Takeda : Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis., Auris, Nasus, Larynx, Vol.48, No.4, 653-658, 2021. (Summary) These findings suggested that SLIT with JC pollen extract suppressed nasal symptoms in patients with JC pollinosis, leading to improvements in AR-related sleep disturbance and daytime troubles with daily life. (Keyword) Adult / Allergens / Case-Control Studies / Cryptomeria / Female / Humans / Male / Middle Aged / Pollen / Quality of Life / Rhinitis, Allergic, Seasonal / Sino-Nasal Outcome Test / Sleep Initiation and Maintenance Disorders / Sublingual Immunotherapy (Link to Publication Site) ● Publication site (DOI): 10.1016/j.anl.2021.01.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33461852 ● Search Scopus @ Elsevier (PMID): 33461852 ● Search Scopus @ Elsevier (DOI): 10.1016/j.anl.2021.01.004 (DOI: 10.1016/j.anl.2021.01.004, PubMed: 33461852)
15.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Kentaro Okamoto, Nanae Sanada, Natsuki Okajima, Tomoharu Wakugawa, Hiroyuki Fukui, Hiroyuki Mizuguchi and Noriaki Takeda : Effects of narrow-band UVB on nasal symptom and upregulation of histamine H1 receptor mRNA in allergic rhinitis model rats, Laryngoscope Investigative Otolaryngology, Vol.6, No.1, 34-41, 2021. (Summary) NA. (Tokushima University Institutional Repository) ● Metadata: 116050 (Link to Publication Site) ● Publication site (DOI): 10.1002/lio2.518 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33614927 ● Search Scopus @ Elsevier (PMID): 33614927 ● Search Scopus @ Elsevier (DOI): 10.1002/lio2.518 (Tokushima University Institutional Repository: 116050, DOI: 10.1002/lio2.518, PubMed: 33614927)
16.	Asami Kageyama, Yoshiaki Kitamura, Hirokazu Koda, Seiichi Nakano, Seiichiro Kamimura, Kazunori Matsuda, Koji Abe and Noriaki Takeda : Transnasal Endoscopic Surgery for Juvenile Angiofibroma Involving the Pterygopalatine Fossa, Japanese Journal of Rhinology, Vol.59, No.4, 318-324, 2020. (Summary) <p>Juvenile angiofibroma (JA) is an uncommon, locally invasive, highly vascular and benign tumor that occurs in adolescent males. Established external surgical procedures for resection of JA include lateral rhinotomy, midfacial degloving, and transpalatal or infratemporal approaches; however, transnasal endoscopic approaches are increasingly being used because of advances in surgical techniques and endoscopic instrumentation. We report the case of a 14-year-old male who presented with left nasal obstruction and repeated epistaxis. A smooth reddish and hemorrhagic tumor was found in the left posterior nasal cavity. Computed tomography and magnetic resonance imaging showed a markedly enhanced tumor of approximately 40 mm in diameter that had obstructed the left posterior nasal cavity and nasopharynx, with occupancy of the pterygopalatine fossa. The case was diagnosed as Radkowski stage IIB. Preoperative embolization was performed to reduce tumor vascularity and improve visualization for surgical removal. Transnasal endoscopic surgery was used to resect the tumor en bloc after clipping the left maxillary artery. Intraoperative bleeding was 80 mL. To prevent recurrence, careful attention must be paid to tumor invasion into the Vidian canal. The postoperative course of our patient was uneventful, and there has been no evidence of recurrence for over one and a half years since surgery.</p> (Link to Publication Site) ● Publication site (DOI): 10.7248/jjrhi.59.318 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1391975831221875712 ● Search Scopus @ Elsevier (DOI): 10.7248/jjrhi.59.318 (DOI: 10.7248/jjrhi.59.318, CiNii: 1391975831221875712)
17.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Hiroyuki Mizuguchi, Keisuke Naito, Eiji Kondou, Kazunori Matsuda, Takahiro Azuma, Gou Satou, Hiroyuki Fukui and Noriaki Takeda : Effects of corticosteroid on mRNA levels of histamine H1 receptor in nasal mucosa of healthy participants and HeLa cells., The Journal of Medical Investigation : JMI, Vol.67, No.3.4, 311-314, 2020. (Summary) The purpose of this study is to examine the effect of intranasal corticosteroid (INCS) administration on histamine H1 receptor (H1R) gene expression in the nasal mucosa of healthy participants and the effects of dexamethasone on basal and histamine-induced H1R mRNA expression, and histamine-induced phosphorylation of extracellular signal-regulated kinase (ERK) in HeLa cells. Sixteen healthy participants were given INCS once daily for a week. After pretreatment of dexamethasone, HeLa cells were treated with histamine. Levels of H1R mRNA and phosphorylation of ERK were measured using real time PCR and immunoblot analysis, respectively. Levels of H1R mRNA in the nasal mucosa of healthy participants receiving INCS was significantly decreased. Dexamethasone suppressed basal levels of H1R mRNA, and histamine-induced up-regulation of H1R mRNA and ERK phosphorylation in HeLa cells. These data suggested that corticosteroid inhibited both basal transcription and histamine-induced transcriptional activation of H1R through its suppression of ERK phosphorylation in the signaling pathway involved in H1R gene transcription. It is further suggested that pre-seasonal prophylactic administration of INCS suppresses both basal and pollen-induced upregulation of H1R gene expression in the nasal mucosa of patients with pollinosis, leading to prevention of the exacerbation of nasal symptoms during peak pollen season. J. Med. Invest. 67 : 311-314, August, 2020. (Tokushima University Institutional Repository) ● Metadata: 115430 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.67.311 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33148907 ● Search Scopus @ Elsevier (PMID): 33148907 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.67.311 (Tokushima University Institutional Repository: 115430, DOI: 10.2152/jmi.67.311, PubMed: 33148907)
18.	Ayaka Yamamoto, Takahiro Azuma, Seiichiro Kamimura, Yoshiaki Kitamura and Noriaki Takeda : A Case of Rosai-Dorfman Disease with Multiple Extranodal Lesion, Practica Oto-Rhino-Laryngologica, Vol.113, No.5, 323-329, 2020. (Summary) <p>Rosai-Dorfman disease is a rare histiocytic disorder characterized by accumulation of histiocytes in the affected tissue. Herein we report on a case of Rosai-Dorfman disease with multiple lymphadenopathy and multiple extranodal lesions. A 22-year-old woman was referred to our hospital with bilateral submandibular swelling and a localized swelling in the root of the nose. Endoscopic examination revealed mass lesions in both nasal cavities and the subglottic area. A full-body CT revealed multiple nasal masses, cervical lymphadenopathy, and an intrathymic mass. We diagnosed her as having Rosai-Dorfman disease based on the histopathological findings of accumulation of histiocytes and emperipolesis in the nasal lesion and cervical lymph node specimens. Histopathological examination is required for the diagnosis of Rosai-Dorfman disease. After steroid treatment for 3 months, reduction in the size of the lymph nodes in the neck, nasal cavity lesions, and intrathymic mass was noted. However, the size of the subglottic mass remained almost unchanged. In this case, steroid treatment was mostly effective on the lesions. In case of airway obstruction due to increase in the size of the subglottic mass, surgical resection should be indicated.</p> (Link to Publication Site) ● Publication site (DOI): 10.5631/jibirin.113.323 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390285300155408000 ● Summary page in Scopus @ Elsevier: 2-s2.0-85087378859 (DOI: 10.5631/jibirin.113.323, CiNii: 1390285300155408000, Elsevier: Scopus)
19.	Seiichi Nakano, Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ヒスタミンH1受容体とIL-33遺伝子発現亢進に対する小青竜湯の抑制効果, Japanese Journal of Rhinology, Vol.59, No.1, 73-74, 2020. (Link to Publication Site) ● Publication site (DOI): 10.7248/jjrhi.59.73 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.7248/jjrhi.59.73 (DOI: 10.7248/jjrhi.59.73)
20.	Gou Satou, Seiichiro Kamimura, Eiji Kondou, Aki Shimada, Kazunori Matsuda, Takahiro Azuma, Yoshiaki Kitamura, Koji Abe and Noriaki Takeda : Effect of Surgical Training Using a Virtual Reality Temporal Bone Simulator in Medical Education, Journal of Otolaryngology of Japa, Vol.122, No.11, 1423-1429, 2019. (Summary) <p> To estimate the effects of a virtual reality temporal bone simulator in medical education.</p><p></p><p> Two hundred and thirty-five medical students undergoing bedside learning were recruited in this study for two years. The same instructor provided the training during the first year, while several instructors provided the training, based on a guidance manual, during the second year. We examined the students' knowledge of anatomy of the temporal bone and administered a questionnaire to determine their comprehension of surgical procedures involving the temporal bone after the training as compared to the level of understanding before the training.</p><p></p><p> The percentage of correct answers in the examination of anatomical knowledge about the temporal bone after the simulation in the first and second year improved from 51.8% to 83.9% and 49.4% to 80.0%, respectively. The percentages of medical students who responded with "well understood" or "I think I understood" to questions in the questionnaire on comprehension of surgical procedures involving the temporal bone in the first and second year were 84.3% and 76.4% for mastoidectomy, 74.8% and 66.4% for tympanotomy and 67.8% and 52.3% for cochleostomy, respectively. The anatomical and surgical comprehension levels, except for the case of cochleostomy, did not differ between students who received instructions from several instructors and those who received from the same instructor in this study. The training using a virtual reality temporal bone simulator was useful to improve the students' anatomical knowledge about the temporal bone and their comprehension of surgical procedures involving the temporal bone, and to unify the training content, regardless of the instructor because of standardization and customization of the surgical procedure. Thus, the training using a virtual reality temporal bone simulator is one of the most effective tools of medical education for both medical students and instructors.</p> (Link to Publication Site) ● Publication site (DOI): 10.3950/jibiinkoka.122.1423 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390283659826292992 ● Summary page in Scopus @ Elsevier: 2-s2.0-85077213217 (DOI: 10.3950/jibiinkoka.122.1423, CiNii: 1390283659826292992, Elsevier: Scopus)

Review, Commentary:

1.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii and Noriaki Takeda : ナローバンドUVB光線療法, アレルギーの臨床, Vol.42, No.13, 1007-1010, Dec. 2022.
2.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, 記本直輝 and Noriaki Takeda : Recent Advances in the Management and Clinical Outcomes of Treatment for Allergic Rhinitis at Tokushima University Hospital, Practica Oto-Rhino-Laryngologica. Suppl., No.158, 175-179, Feb. 2022. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390010610459661440 (CiNii: 1390010610459661440)
3.	Yoshiaki Kitamura, 黒田若奈, Hideyuki Nakagawa, Tatsuya Fujii, Seiichi Nakano, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : アレルギー性鼻炎におけるヒスタミンH₁受容体遺伝子発現亢進の分子機構とその制御 (武田憲昭教授退任記念総説集), Practica Oto-Rhino-Laryngologica. Suppl., No.158, 1-11, Feb. 2022. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390855035370803968 (CiNii: 1390855035370803968)
4.	Yoshiaki Kitamura, Tomoharu Wakugawa, Seiichi Nakano, Seiichiro Kamimura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : Role of Nuclear Factor of Activated T Cells Signaling in the Development of Allergic Rhinitis, Practica Oto-Rhino-Laryngologica. Suppl., No.158, 12-19, Feb. 2022. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390573560413082752 (CiNii: 1390573560413082752)

Proceeding of International Conference:

1.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : Development of an intranasal phototherapy device for allergic rhinitis using LEDs emitting narrowband-UVB, 18th Japan-Korea Joint Meeting of Otorhinolaryngology - Head and Neck Surgery (JKJM2022), Apr. 2022.
2.	Seiichiro Kamimura, Yoshiaki Kitamura, Sanada Nanae, Okamoto Kentaro, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : Irradiation with narrow-band-ultraviolet B suppresses up-regulation of histamine H1 receptor mRNA in the nasal mucosa of rat model of allergic rhinitis, World Histamine Symposium 2018, Jul. 2018.

Proceeding of Domestic Conference:

1.	Eiji Kondou, ISHITANI Keisuke, TOMURA Miki, Ryo Kanamura, Seiichiro Kamimura, Takahiro Azuma and Yoshiaki Kitamura : 喉頭気管分離術を施行した重症心身障碍児15例のカニューレ・呼吸器管理についての検討喉頭喉頭気管分離術を施行した重症心身障碍児15例のカニューレ・呼吸器管理についての検討, 第47回日本嚥下医学会総会・学術講演会, Feb. 2024.
2.	Sonoko Yasui-Yamada, Miyu Kubo, Yuna Izumi, Kazuhiro Nomura, Seiichiro Kamimura, Hideya Kashihara, Yu Saitou, Yoshiaki Kitamura, Mitsuo Shimada, Yasuhiro Hamada and Hiroshi Sakaue : 簡便に得られるデータから作成した四肢骨格筋量を予測する回帰式の妥当性検証, 第27回日本病態栄養学会年次学術集会, Jan. 2024.
3.	Aki Endo, TAKAOKA Sho, Seiichiro Kamimura, Gou Satou and Yoshiaki Kitamura : 当科におけるバーチャルリアリティ(VR)シミュレーターによる側頭骨手術・内視鏡下鼻副鼻腔手術の医学教育実習の効果, 日本耳鼻咽喉科頭頸部外科学会第49回四国四県地方部会, Dec. 2023.
4.	Takahiro Azuma, Mika Takahashi, Eiji Kondou, Seiichiro Kamimura, Gou Satou, Noriaki Takeda and Yoshiaki Kitamura : 病的共同運動に対するボツリヌス毒素療法とボツリヌス毒素・ミラーバイオフィードバック併用療法の長期成績, 第33回日本耳科学会, Nov. 2023.
5.	Seiichiro Kamimura, ISHITANI Keisuke, Tatsuya Fujii and Yoshiaki Kitamura : 通年性アレルギー性鼻炎に対する後鼻神経切断の長期効果の検討, 第72回日本アレルギー学会, Oct. 2023.
6.	ISHITANI Keisuke, Seiichiro Kamimura, Tatsuya Fujii and Yoshiaki Kitamura : 経結膜と内視鏡下経鼻のcombined approachにより整復した眼窩底骨折の2例, 第62回日本鼻科学会, Sep. 2023.
7.	Tatsuya Fujii, KAGEYAMA Asami, ISHITANI Keisuke, Seiichiro Kamimura and Yoshiaki Kitamura : ダニ舌下免疫療法の3年継続例と脱落例の比較検討, 第62回日本鼻科学会, Sep. 2023.
8.	Seiichiro Kamimura, ISHITANI Keisuke, Tatsuya Fujii and Yoshiaki Kitamura : ESS未実施および単洞化が不良な好酸球性副鼻腔炎例に対するデュピルマブの効果, 第62回日本鼻科学会, Sep. 2023.
9.	Aki Endo, 記本直輝, ISHITANI Keisuke, Seiichiro Kamimura, Eiji Kondou and Yoshiaki Kitamura : 鼻咽腔原発の小児リンパ腫の2例, 日耳鼻第48回中国四国地方部会, Jul. 2023.
10.	Yuki Ishitani, Ryo Kanamura, Seiichiro Kamimura, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 当科における耳下腺手術174例の検討, 第124回日本耳鼻咽喉科頭頸部外科学会, May 2023.
11.	Hitoshi Shono, Ryo Kanamura, Seiichiro Kamimura, Eiji Kondou, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 食事へのグルタミン酸Naの添加が健常女性の舌粘膜のT1R3味覚受容体遺伝子発現と食事摂取に与える影響, 第124回日本耳鼻咽喉科頭頸部外科学会, May 2023.
12.	ISHITANI Keisuke, Seiichiro Kamimura and Yoshiaki Kitamura : 当科における好酸球性副鼻腔炎に合併した好酸球性中耳炎に対するデュピルマブの効果の検討, 第124回日本耳鼻咽喉科頭頸部外科学会, May 2023.
13.	Ryo Kanamura, Hitoshi Shono, Seiichiro Kamimura, Eiji Kondou, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 当科における頭頸部再建手術75例の検討, 第124回日本耳鼻咽喉科頭頸部外科学会, May 2023.
14.	Seiichiro Kamimura, ISHITANI Keisuke, Tatsuya Fujii and Yoshiaki Kitamura : 後鼻神経切断術の長期効果の検討, 第3回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2023.
15.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : スギ花粉舌下免疫療法と初期療法がスギ花粉症患者の症状とQOLに与える影響 ―2020年と2022年の比較―, 第3回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2023.
16.	ISHITANI Keisuke, Seiichiro Kamimura and Yoshiaki Kitamura : 好酸球性副鼻腔炎に合併した好酸球性中耳炎に対するデュピルマブの効果の検討, 第3回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2023.
17.	記本直輝, Ryo Kanamura, Yuki Ishitani, ISHITANI Keisuke, Seiichiro Kamimura, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 右側頸部に発生した甲状舌管嚢胞に伴う異所性甲状腺癌の2 例, 第32回日本頭頸部外科学会, Jan. 2023.
18.	Yuki Ishitani, ISHITANI Keisuke, 記本直輝, Ryo Kanamura, Seiichiro Kamimura, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 内視鏡下鼻内手術にて摘出した鼻口蓋管嚢胞例, 第32回日本頭頸部外科学会, Jan. 2023.
19.	Ryo Kanamura, 記本直輝, Yuki Ishitani, Seiichiro Kamimura, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 当科における喉頭癌 89 例の検討, 第32回日本頭頸部外科学会, Jan. 2023.
20.	Seiichiro Kamimura, Yuki Ishitani, ISHITANI Keisuke, Ryo Kanamura, Takahiro Azuma, Gou Satou and Yoshiaki Kitamura : 鼻中隔後端に生じたThyroid-like low-grade nasopharyngeal papillary adenocarcinoma 例, 第32回日本頭頸部外科学会, Jan. 2023.
21.	OMAE Nao, Sonoko Yasui-Yamada, Nanako Hamamiya, YAMANAKA Ayaka, MATSUOKA Momoyo, Seiichiro Kamimura, Yoshiaki Kitamura and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と化学療法中断・生存率との関連, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
22.	山本綾香, 蔭山麻美, Seiichiro Kamimura, Yuki Ishitani, Eiji Kondou and Yoshiaki Kitamura : 副甲状腺の同定・温存にORBEYEが有用であった甲状腺全摘術例, 日本耳鼻咽喉科頭頸部外科学会第48回四国四県地方部会連合学会, Dec. 2022.
23.	古本太希, 近藤心, 山田めぐみ, Nori Sato, Seiichiro Kamimura, Yoshiaki Kitamura, Sonoko Yasui-Yamada, Yasuhiro Hamada, Shinsuke Katoh and Tetsuya Matsuura : 化学放射線治療中の頭頚部がん患者に対する理学療法の実施率の違いが筋量，筋力，身体機能に及ぼす影響, 四国理学療法士会学会誌, No.44, 102-103, Nov. 2022.
24.	Gou Satou, Junya Fukuda, Seiichiro Kamimura, Eiji Kondou, Mika Takahashi, Takahiro Azuma, Yoshiaki Kitamura and Noriaki Takeda : ハント症候群患者のめまいの自覚症状と前庭機能の長期予後, 第32回日本耳科学会, Oct. 2022.
25.	Takahiro Azuma, Eiji Kondou, Seiichiro Kamimura, Junya Fukuda, Gou Satou, Yoshiaki Kitamura and Noriaki Takeda : 鼓室形成術後に発症した聴器癌例, 第32回日本耳科学会, Oct. 2022.
26.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : スギ花粉舌下免疫療法と初期療法が少量飛散年と大量飛散年にスギ花粉症患者の症状とQOLに与える影響, 第61回日本鼻科学会, Oct. 2022.
27.	Seiichiro Kamimura, Yoshiaki Kitamura, 蔭山麻美 and Noriaki Takeda : Dupilumabを投与した好酸球性副鼻腔炎例の検討, 第61回日本鼻科学会, Oct. 2022.
28.	Yoshiaki Kitamura, Seiichiro Kamimura, 蔭山麻美 and Noriaki Takeda : Endoscopic modified medial maxillectomy症例の検討, 第61回日本鼻科学会, Oct. 2022.
29.	ISHITANI Keisuke, Seiichiro Kamimura, Ryo Kanamura, Junya Fukuda, Eiji Kondou, Takahiro Azuma, Yoshiaki Kitamura and Noriaki Takeda : 当科における好酸球性副鼻腔炎に対するdupilumabの治療効果の検討, 第265回徳島医学会学術集会, Jul. 2022.
30.	石谷えみ, 記本直輝, 蔭山麻美, Seiichiro Kamimura, Eiji Kondou, Gou Satou and Yoshiaki Kitamura : 粘膜類天疱瘡による咽喉頭潰瘍を来した2例, 第84回耳鼻咽喉科臨床学会, Jul. 2022.
31.	蔭山麻美, MATSUOKA Momoyo, Aki Endo, Ryo Kanamura, Seiichiro Kamimura, Gou Satou, Yoshiaki Kitamura and Noriaki Takeda : 経鼻内視鏡下に摘出した上顎洞エナメル性上皮腫例, 日本耳鼻咽喉科学会第47回中国四国地方部会連合学会, Jun. 2022.
32.	Seiichiro Kamimura, Yoshiaki Kitamura, 蔭山麻美, 石谷えみ, Junya Fukuda, Takahiro Azuma, Gou Satou and Noriaki Takeda : バーチャルリアリティーを用いた内視鏡下副鼻腔手術シミュレーターによる医学教育実習の効果, 第123回日本耳鼻咽喉科頭頸部外科学会総会, May 2022.
33.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Hiroyuki Fukui, Hiroyuki Mizuguchi and Noriaki Takeda : ピロガロールの NFAT シグナルを介した IL-9 遺伝子発現亢進の抑制, 第2回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2022.
34.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : スギ花粉舌下免疫療法と初期療法のスギ花粉少量飛散年と大量飛散年での効果の比較, 第2回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2022.
35.	Seiichiro Kamimura, Yoshiaki Kitamura and Noriaki Takeda : Dupilumab 初回投与後に好酸球性多発血管炎性肉芽腫症を発症した好酸球性副鼻腔炎例, 第2回日本耳鼻咽喉科免疫アレルギー感染症学会, Apr. 2022.
36.	ISHITANI Keisuke, Eiji Kondou, Ryo Kanamura, Seiichiro Kamimura, Takahiro Azuma, Gou Satou, Yoshiaki Kitamura, Koji Abe, Koichi Tamura and Noriaki Takeda : 当科での下咽頭癌の臨床統計, 第31回日本頭頸部外科学会, Mar. 2022.
37.	yamanaka ayaka, Sonoko Yasui-Yamada, omae nao, wada kyoko, kitao midori, hayashi haruka, kubo miyu, Yumiko Kurokawa, Yoshiko Suzuki, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者における化学放射線療法前のPhase Angleと予後との関連, 第24回・第25回日本病態栄養学会年次学術集会, Jan. 2022.
38.	石谷えみ, Ryo Kanamura, 記本直輝, Seiichiro Kamimura and Yoshiaki Kitamura : 舌癌治療後9年目に発症した原発不明頸部転移腺癌例, 日本耳鼻咽喉科学会第47回四国四県地方部会, Dec. 2021.
39.	記本直輝, Seiichiro Kamimura, ISHITANI Keisuke, Yoshiaki Kitamura and Noriaki Takeda : Dupilumab投与後に好酸球性多発血管炎性肉芽腫症を発症した好酸球性副鼻腔炎症例, 日本耳鼻咽喉科学会第47回四国四県地方部会, Dec. 2021.
40.	Seiichiro Kamimura, Yoshiaki Kitamura, 蔭山麻美 and Noriaki Takeda : 医学教育におけるバーチャルリアリティーを用いた内視鏡下副鼻腔手術シミュレーション実習の効果, 第60回日本鼻科学会, Oct. 2021.
41.	Yoshiaki Kitamura, Seiichiro Kamimura, 蔭山麻美 and Noriaki Takeda : 浸潤性副鼻腔炎の手術症例の検討, 第60回日本鼻科学会, Oct. 2021.
42.	記本直輝, Ryo Kanamura, Seiichiro Kamimura, 蔭山麻美, Aki Endo, Takahiro Azuma and Noriaki Takeda : ニボルマブ投与後に発症したStevens-Jonson syndrome例, 日本耳鼻咽喉科学会第46回中国四国地方部会連合学会, Jul. 2021.
43.	Seiichiro Kamimura, Katsuya Fujino, 内藤圭介, Yoshiaki Kitamura and Noriaki Takeda : 上顎洞嚢胞に対して全身麻酔下に内視鏡下鼻内副鼻腔手術を行った遺伝性血管性浮腫例, 第1回日本耳鼻咽喉科免疫アレルギー感染症学会, Jul. 2021.
44.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : 抗ヒスタミン薬のインバースアゴニスト作用とヒスタミンH1受容体遺伝子発現抑制効果の検討, 第1回日本耳鼻咽喉科免疫アレルギー感染症学会, Jul. 2021.
45.	Tatsuya Fujii, Yoshiaki Kitamura and Seiichiro Kamimura : 当科におけるダニ舌下免疫療法の治療効果, 第1回日本耳鼻咽喉科免疫アレルギー感染症学会, Jul. 2021.
46.	Eiji Kondou, Seiichiro Kamimura, 松岡百百世, 蔭山麻美, 矢野流美, Aki Shimada, Takahiro Azuma, Yoshiaki Kitamura, Koji Abe and Noriaki Takeda : 気管弁法を用いた小児の喉頭気管分離術14例の検討, 第122回日本耳鼻咽喉科学会, May 2021.
47.	Seiichiro Kamimura, Koji Abe, Katsuya Fujino, Kazunori Matsuda and Noriaki Takeda : 舌に生じた髄外性形質細胞腫の1例, 第82回日本耳鼻咽喉科臨床学会, Dec. 2020.
48.	矢野流美, 蔭山麻美, MATSUOKA Momoyo, 石谷えみ, Seiichiro Kamimura, Takahiro Azuma, Gou Satou and Noriaki Takeda : 舌下神経麻痺をきたした悪性外耳道炎例, 日本耳鼻咽喉科学会第46回四国四県地方部会連合学会, Dec. 2020.
49.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii and Noriaki Takeda : 鼻弁狭窄による鼻閉に対するopen septorhinoplasty治療例, 第59回日本鼻科学会, Oct. 2020.
50.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Seiichi Nakano and Noriaki Takeda : 当院における好酸球性副鼻腔炎の術後1年以内のステロイド内服薬投与例の検討, 第59回日本鼻科学会, Oct. 2020.
51.	Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii and Noriaki Takeda : アレルギー性鼻炎に対するナローバンドUVB 光治療装置の開発, 第121回日本耳鼻咽喉科学会学術講演会, Oct. 2020.
52.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : スギ花粉舌下錠による舌下免疫療法の鼻症状と睡眠障害に対する効果, 第121回日本耳鼻咽喉科学会学術講演会, Oct. 2020.
53.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Fukui, Hiroyuki Mizuguchi and Noriaki Takeda : Intranasal irradiation with narrowband-ultraviolet B suppresses nasal symptoms and up-regulation of histamine H1receptor mRNA in the nasal mucosa of rat model of allergic rhinitis, 第69回日本アレルギー学会学術大会, Sep. 2020.
54.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ナローバンドUVB光線療法のアレルギー性鼻炎モデルラットの鼻粘膜ヒスタミンH1受容体遺伝子発現と鼻症状に対する効果, 第38回日本耳鼻咽喉科免疫アレルギー学会, Sep. 2020.
55.	Seiichi Nakano, Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : アレルギー性鼻炎のヒスタミンH1受容体とIL-33遺伝子発現亢進に対する小青竜湯と生薬の抑制効果の検討, 第38回日本耳鼻咽喉科免疫アレルギー学会, Sep. 2020.
56.	Yoshiaki Kitamura, Seiichiro Kamimura, Seiichi Nakano, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : アレルギー性鼻炎のヒスタミンH1受容体遺伝子発現亢進機構に対するステロイドの抑制効果の検討, 第38回日本耳鼻咽喉科免疫アレルギー学会, Sep. 2020.
57.	Midori Kitao, Sonoko Yasui-Yamada, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の有害事象の頻度と食事摂取への影響について, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
58.	Sonoko Yasui-Yamada, Taiki Furumoto, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化 ∼BIA，エコー，メジャーを用いた経時的評価∼, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
59.	Yoshiaki Kitamura, Seiichiro Kamimura, Kazunori Matsuda, Takahiro Azuma, Gou Satou, Koji Abe and Noriaki Takeda : 若年性血管線維腫摘出術における翼突管と蝶形骨洞隔壁の検討, 第30回日本頭頸部外科学会, Jan. 2020.
60.	Seiichiro Kamimura, Yoshiaki Kitamura, Koji Abe and Noriaki Takeda : 副鼻腔CTと未固定遺体による篩骨動脈のfloat症例の検討, 第30回日本頭頸部外科学会, Jan. 2020.
61.	蔭山麻美, 山本綾香, Kazunori Matsuda, Takahiro Azuma, Seiichiro Kamimura, Yoshiaki Kitamura and Noriaki Takeda : 耳かき外傷により耳小骨離断と顔面神経麻痺を来した小児例, 日本耳鼻咽喉科学会第45回四国四県地方部会連合学会, Dec. 2019.
62.	Sonoko Yasui-Yamada, Taiki Furumoto, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : NST介入例における頭頸部癌化学放射線療法中の体組成変化∼BIA，エコー，メジャーを用いた評価∼, 第9回日本リハビリテーション栄養学会, Nov. 2019.
63.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : 当科におけるスギ花粉症とダニの併用舌下免疫療法の有効性と安全性の検討, 第58回日本鼻科学会, Oct. 2019.
64.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii and Noriaki Takeda : 副鼻腔CTによる前・後篩骨動脈の頭蓋底からの距離と走行位置に関する検討, 第58回日本鼻科学会, Oct. 2019.
65.	Yoshiaki Kitamura, Seiichiro Kamimura, Kazunori Matsuda and Noriaki Takeda : 経鼻内視鏡下に摘出した翼口蓋窩に進展した若年性血管線維腫例, 第58回日本鼻科学会, Oct. 2019.
66.	Seiichi Nakano, Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ヒスタミンH1受容体とIL-33遺伝子発現亢進に対する小青竜湯の抑制効果, 第58回日本鼻科学会, Oct. 2019.
67.	幸田裕和, Yoshiaki Kitamura, Seiichiro Kamimura, Seiichi Nakano and Noriaki Takeda : 経鼻内視鏡下に切除し得た若年性血管線維腫例, 日本耳鼻咽喉科学会第45回中国四国地方部会, Jun. 2019.
68.	Yoshiaki Kitamura, Seiichiro Kamimura, Seiichi Nakano, Tatsuya Fujii and Noriaki Takeda : スギ花粉症に対する初期療法の鼻粘膜ヒスタミンH1 受容体遺伝子発現への効果, 第120回日本耳鼻咽喉科学会, May 2019.
69.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Taiki Furumoto, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と栄養量との関係, 第34回日本静脈経腸栄養学会学術集会, Feb. 2019.
70.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi and Hiroyuki Fukui : ナローバンドUVB照射のHeLa細胞およびTDIアレルギー性鼻炎モデルラットのヒスタミンH1受容体遺伝子発現亢進への影響, 第37回日本耳鼻咽喉科免疫アレルギー学会, Feb. 2019.
71.	Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : プロテインキナーゼCσシグナルの抑制によるヒスタミンH1受容体とIL-33遺伝子発現亢進の抑制効果, 第37回日本耳鼻咽喉科免疫アレルギー学会, Feb. 2019.
72.	Midori Kitao, Sonoko Yasui-Yamada, Haruka Hayashi, Miyu Kubo, Kyoko Wada, 安原香代美, 井川友美, Yoshiko Suzuki, Akiko Matsumura, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の有害事象の頻度と食事摂取量への影響について, 第22回日本病態栄養学会学術集会, Jan. 2019.
73.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Taiki Furumoto, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体重変化と栄養組成との関係, 第22回日本病態栄養学会学術集会, Jan. 2019.
74.	Seiichiro Kamimura, Yoshiaki Kitamura, Seiichi Nakano, Noriaki Takeda and Tatsuya Fujii : ナローバンドUVB照射のHeLa細胞およびTDIアレルギー性鼻炎モデルラットのヒスタミンH1受容体遺伝子発現亢進への影響, 日本耳鼻咽喉科学会第44回四国四県地方部会, Dec. 2018.
75.	Gou Satou, Seiichiro Kamimura, Aki Endo, Eiji Kondou, Takahiro Azuma, Koji Abe and Noriaki Takeda : 医学教育に対するバーチャルリアリティーを用いた側頭骨手術シミュレーション実習の効果, 第28回日本耳科学会, Oct. 2018.
76.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura and Noriaki Takeda : 鼻中隔から発生した多形腺腫瘍, 第57回日本鼻科学会, Sep. 2018.
77.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ナローバンドUVBがアレルギー性鼻炎モデルラットの鼻症状とヒスタミンH1受容体遺伝子発現亢進に与える影響, 第57回日本鼻科学会, Sep. 2018.
78.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : 鼻副鼻腔乳頭腫の腫瘍マーカーとしての血中SCC抗原の検討, 第57回日本鼻科学会, Sep. 2018.
79.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Taiki Furumoto, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と栄養量との関係について, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
80.	Fumihiro Fukuhara, Eiji Kondou, Seiichiro Kamimura, Seiichi Nakano, Gou Satou and Noriaki Takeda : 顎下部に結節を生じた外歯瘻の1例, 日本耳鼻咽喉科学会第44回中国四国地方連合学会, Jun. 2018.
81.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ナローバンドUVBのアレルギー性鼻炎モデルラットの鼻症状と鼻粘膜ヒスタミンH1受容体遺伝子発現への影響, 第67回日本アレルギー学会学術大会, Jun. 2018.
82.	Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ナローバンドUVBがアレルギー性鼻炎モデルラットの鼻症状とH1受容体遺伝子発現亢進に与える影響, 第119回日本耳鼻咽喉科学会総会, May 2018.
83.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : ナローバンドUVB光線療法のアレルギー性鼻炎モデルラットの鼻症状と鼻粘膜ヒスタミンH1受容体遺伝子発現に対する効果, 第36回日本耳鼻咽喉科免疫アレルギー学会, Feb. 2018.
84.	Yoshiaki Kitamura, Seiichiro Kamimura, Hiroyuki Mizuguchi, Hiroyuki Fukui and Noriaki Takeda : スプラタストのNFATシグナルを介したIL-9遺伝子発現抑制効果, 第36回日本耳鼻咽喉科免疫アレルギー学会, Feb. 2018.
85.	Miyu Kubo, Sonoko Yasui-Yamada, Haruka Hayashi, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Seiichiro Kamimura, 三好仁美, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者において24時間尿中クレアチニン排泄量は骨格筋量評価に有用か, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
86.	Miyu Kubo, 山田苑子, Haruka Hayashi, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Seiichiro Kamimura, 三好仁美, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者において24時間尿中クレアチニン排泄量は骨格筋量評価に有用, The Journal of Metabolism and Clinical Nutrition, Vol.21, Jan. 2018.
87.	Kazunori Matsuda, Gou Satou, 蔭山麻美, Ryo Kanamura, Seiichiro Kamimura, Aki Endo and Noriaki Takeda : 一側内耳破壊術術後のラットにおける免疫組織化学的手法を用いた前庭代償の進行過程の可視化, 日本耳鼻咽喉科学会第43回四国四県地方部会連合学会, Dec. 2017.
88.	Yoshiaki Kitamura, Seiichiro Kamimura, Kazunori Matsuda and Noriaki Takeda : 視神経管に浸透した蝶型骨洞内反性乳頭腫再発例, 第56回日本鼻科学会, Sep. 2017.
89.	Seiichiro Kamimura, Yoshiaki Kitamura, Tatsuya Fujii and Noriaki Takeda : 好酸球性副鼻腔炎患者における血中EPA/AA比の検討, 第56回日本鼻科学会, Sep. 2017.
90.	両角遼太, Mika Takahashi, Seiichiro Kamimura, Seiichi Nakano, Yoshiaki Kitamura, Noriaki Takeda and 戸村美紀 : フソバクテリウム感染による耳下腺炎症例, 日本耳鼻咽喉科学会第43回中国四国地方部会, Jun. 2017.

Et cetera, Workshop:

1.	Seiichiro Kamimura : 最新のアレルギー性鼻炎の治療について ∼花粉症2024∼, 第154回徳島県耳鼻咽喉科医会研修会, Oct. 2023.
2.	Seiichiro Kamimura : 好酸球性副鼻腔炎に対するESS後のマネージメント∼Bio製剤導入の最適なタイミングとは?∼, Meet the surgical Expert in 四国, Jul. 2023.
3.	Seiichiro Kamimura : 好酸球性副鼻腔炎に対するデュピルマブの効果と今後の展開, Apr. 2023.
4.	Seiichiro Kamimura : アレルギー性鼻炎・耳鼻科医が診る咳嗽疾患について, 杏林製薬株式会社徳島営業所社内勉強会, Mar. 2023.
5.	Seiichiro Kamimura : アレルギー性鼻炎の治療について, どこでもビラノアオンラインセミナー, Feb. 2023.
6.	Seiichiro Kamimura : アレルギー性鼻炎の治療について, Meijiアレルギーセミナー in 高知, Jan. 2023.
7.	Seiichiro Kamimura : 耳鼻咽喉科アレルギー外来での取り組み, 総合アレルギーセンター院内連携カンファレンス, Nov. 2022.
8.	Seiichiro Kamimura : スギ花粉症の診断と治療, 美馬市医師会学術講演会, Mar. 2022.
9.	Seiichiro Kamimura : ナローバンドUVBがアレルギー性鼻炎モデルラットの鼻症状とヒスタミンH1受容体mRNAの発現亢進へ与える影響, 第149回徳島県耳鼻咽喉科医会研修会, Jan. 2022.
10.	Seiichiro Kamimura : アレルギー性鼻炎の診断と治療 Up to date ∼口腔アレルギー症候群の話題も含めて∼, 第149回徳島県耳鼻咽喉科医会研修会, Jan. 2022.
11.	Seiichiro Kamimura : アレルギー性鼻炎治療における舌下免疫療法と抗ヒスタミン薬, 高岡郡医師会学術講演会, Feb. 2020.
12.	Taiki Furumoto, Sonoko Yasui-Yamada, 近藤心, Akiko Matsumura, Nori Sato, Seiichiro Kamimura, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 化学放射線治療中の頭頸部癌患者における二次性サルコペニアの発生状況, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Treatment of allergic rhinitis by intranasal irradiation with narrowband-UVB (Project/Area Number: 24K19753 )
The mechanism of inverse agonism in preseasonal prophylactic treatment with antihistamines for pollinosis (Project/Area Number: 24K12648 )
Treatment of allergic rhinitis with intranasal NB-UVB irradiation (Project/Area Number: 20K18254 )
Effect of IL-33 Gene Expression suppression on allergic rhinitis (Project/Area Number: 20K09693 )
Search by Researcher Number (90867194)

Associate Professor : Kamimura, Seiichiro

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)